JP2013078329A5 - - Google Patents

Download PDF

Info

Publication number
JP2013078329A5
JP2013078329A5 JP2012264713A JP2012264713A JP2013078329A5 JP 2013078329 A5 JP2013078329 A5 JP 2013078329A5 JP 2012264713 A JP2012264713 A JP 2012264713A JP 2012264713 A JP2012264713 A JP 2012264713A JP 2013078329 A5 JP2013078329 A5 JP 2013078329A5
Authority
JP
Japan
Prior art keywords
seq
dehalogenase
mutant dehalogenase
mutant
substitution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012264713A
Other languages
English (en)
Japanese (ja)
Other versions
JP5840117B2 (ja
JP2013078329A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2013078329A publication Critical patent/JP2013078329A/ja
Publication of JP2013078329A5 publication Critical patent/JP2013078329A5/ja
Application granted granted Critical
Publication of JP5840117B2 publication Critical patent/JP5840117B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012264713A 2006-10-30 2012-12-03 キネティクス及び機能発現が高められた突然変異形ヒドロラーゼ・タンパク質 Active JP5840117B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US85523706P 2006-10-30 2006-10-30
US60/855,237 2006-10-30
US93020107P 2007-05-15 2007-05-15
US60/930,201 2007-05-15

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2009534717A Division JP5680302B2 (ja) 2006-10-30 2007-10-30 キネティクス及び機能発現が高められた突然変異形ヒドロラーゼ・タンパク質

Publications (3)

Publication Number Publication Date
JP2013078329A JP2013078329A (ja) 2013-05-02
JP2013078329A5 true JP2013078329A5 (https=) 2013-10-03
JP5840117B2 JP5840117B2 (ja) 2016-01-06

Family

ID=39344927

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009534717A Active JP5680302B2 (ja) 2006-10-30 2007-10-30 キネティクス及び機能発現が高められた突然変異形ヒドロラーゼ・タンパク質
JP2012264713A Active JP5840117B2 (ja) 2006-10-30 2012-12-03 キネティクス及び機能発現が高められた突然変異形ヒドロラーゼ・タンパク質

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2009534717A Active JP5680302B2 (ja) 2006-10-30 2007-10-30 キネティクス及び機能発現が高められた突然変異形ヒドロラーゼ・タンパク質

Country Status (5)

Country Link
US (5) US8420367B2 (https=)
EP (4) EP2087107A2 (https=)
JP (2) JP5680302B2 (https=)
CA (1) CA2667697A1 (https=)
WO (1) WO2008054821A2 (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7429472B2 (en) 2003-01-31 2008-09-30 Promega Corporation Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule
EP2341134B1 (en) 2003-01-31 2014-08-27 Promega Corporation Covalent tethering of functional groups to proteins
US7425436B2 (en) 2004-07-30 2008-09-16 Promega Corporation Covalent tethering of functional groups to proteins and substrates therefor
EP2087107A2 (en) 2006-10-30 2009-08-12 Promega Corporation Mutant hydrolase proteins with enhanced kinetics and functional expression
WO2012061477A1 (en) 2010-11-02 2012-05-10 Promega Corporation Coelenterazine derivatives and methods of using same
BR112013010487B1 (pt) 2010-11-02 2021-02-02 Promega Corporation compostos de coelenterazina, kit compreendendo ditos compostos e método para detectar luminescência em uma amostra in vitro
SG11201500799YA (en) 2012-07-31 2015-03-30 Basil M Hantash Hla g-modified cells and methods
EP2969435B1 (en) 2013-03-15 2021-11-03 Promega Corporation Substrates for covalent tethering of proteins to functional groups or solid surfaces
US9790537B2 (en) 2014-01-29 2017-10-17 Promega Corporation Quinone-masked probes as labeling reagents for cell uptake measurements
US9927430B2 (en) 2014-01-29 2018-03-27 Promega Corporation Pro-substrates for live cell applications
KR20190025362A (ko) * 2017-09-01 2019-03-11 삼성전자주식회사 할로산 데할로게나제 수퍼패밀리 단백질 변이체 및 그를 이용한 시료 중 불소 함유 화합물의 농도를 감소시키는 방법
CN119264211A (zh) 2018-08-27 2025-01-07 瑞泽恩制药公司 拉曼光谱在下游纯化中的应用
WO2020175502A1 (ja) * 2019-02-27 2020-09-03 国立大学法人東京医科歯科大学 抗原結合タンパク質と蛍光タンパク質または蛍光標識されるタグタンパク質との融合タンパク質
CN110819612A (zh) * 2019-11-29 2020-02-21 天津科技大学 新型抗自切碱性蛋白酶的筛选
KR20230147105A (ko) 2021-01-28 2023-10-20 진콴텀 헬스케어 (쑤저우) 씨오., 엘티디. 리가제 융합 단백질 및 그 응용
JP7851558B2 (ja) * 2021-02-19 2026-04-27 国立研究開発法人産業技術総合研究所 標的タンパク質の生産方法
CN115322980B (zh) * 2021-05-11 2024-04-02 中国科学院化学研究所 酰胺水解酶突变体及其在手性环状化合物合成上的应用
US12043862B2 (en) 2021-12-28 2024-07-23 Encodia, Inc. High-throughput serotyping and antibody profiling assays
EP4519426A2 (en) 2022-05-04 2025-03-12 Promega Corporation Split modified dehalogenase variants
US20240060059A1 (en) * 2022-05-04 2024-02-22 Promega Corporation Circularly permuted dehalogenase variants
JP2025515181A (ja) * 2022-05-04 2025-05-13 プロメガ コーポレイション 伸長表面ループ領域を有する修飾デハロゲナーゼ
WO2023215497A1 (en) 2022-05-04 2023-11-09 Promega Corporation Photoactivatable compounds and uses thereof
AU2023296781A1 (en) 2022-07-01 2025-02-13 Genequantum Healthcare (Suzhou) Co., Ltd. Immobilized endoglycosidase fusion protein and use thereof
AU2024265176A1 (en) * 2023-05-04 2025-12-11 Promega Corporation Complementation-based tags and reporters for dual-modality labeling
WO2025090949A1 (en) * 2023-10-27 2025-05-01 Trustees Of Tufts College Fluorogenic self-labeling enzyme compositions, systems, and kits
CN118165960B (zh) * 2024-03-25 2025-03-25 南京大学 一种内切β-1,4-葡聚糖酶突变体及其基因、载体和制备方法

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3131122A (en) * 1961-04-14 1964-04-28 Boehringer Sohn Ingelheim Method of producing analgesia with n-substituted-4-phenyl-4-carbalkoxypiperidines
DE1229532B (de) 1961-04-14 1966-12-01 Boehringer Sohn Ingelheim Verfahren zur Herstellung neuer Piperidinderivate
US3420367A (en) 1967-05-25 1969-01-07 Du Pont Multiple container package
US4574079A (en) * 1983-05-27 1986-03-04 Gavras Haralambos P Radiolabeled angiotensin converting enzyme inhibitors for radiolabeling mammalian organ sites
US4612302A (en) 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
US4684620A (en) 1984-09-04 1987-08-04 Gibson-Stephens Neuropharmaceuticals, Inc. Cyclic polypeptides having mu-receptor specificity
US4812409A (en) 1986-01-31 1989-03-14 Eastman Kodak Company Hydrolyzable fluorescent substrates and analytical determinations using same
US4853371A (en) 1986-06-17 1989-08-01 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
EP0258898B1 (en) * 1986-09-04 1992-04-22 Idemitsu Kosan Company Limited Liquid-crystalline polymer
US4810636A (en) 1986-12-09 1989-03-07 Miles Inc. Chromogenic acridinone enzyme substrates
CS259396B1 (sk) 1987-05-06 1988-10-14 Jozef Luston l,2,2,6,6-PentametyI-4-(w-brĎmalkoxy)piperidíny a spásob ich přípravy
SE8900130L (sv) * 1989-01-16 1990-07-17 Klaus Mosbach Konceptet att med hjaelp av molekylavtrycksmetoden framstaella konstgjorda antikroppar genom imprinting av t ex antigener samt att framstaella konstgjorda entzymer genom imprintning med transition state analoger
US5071469A (en) * 1989-04-21 1991-12-10 E. I. Du Pont De Nemours And Company Herbicidal benzylsulfonamides
US5498694A (en) * 1989-05-25 1996-03-12 La Jolla Cancer Research Foundation Peptides of the cytoplasmic domain of integrin
US5128247A (en) * 1989-08-14 1992-07-07 Board Of Regents, The University Of Texas System Methods for isolation of nucleic acids from eukaryotic and prokaryotic sources
US5099020A (en) * 1989-11-27 1992-03-24 Abbott Laboratories Barbiturate assay compositions and methods
CA2095633C (en) * 1990-12-03 2003-02-04 Lisa J. Garrard Enrichment method for variant proteins with altered binding properties
US5576424A (en) * 1991-08-23 1996-11-19 Molecular Probes, Inc. Haloalkyl derivatives of reporter molecules used to analyze metabolic activity in cells
FR2700855B1 (fr) 1993-01-28 1995-03-03 Commissariat Energie Atomique Dosage immunométrique d'un antigène ou d'un haptène.
US6118047A (en) 1993-08-25 2000-09-12 Dekalb Genetic Corporation Anthranilate synthase gene and method of use thereof for conferring tryptophan overproduction
US5372944A (en) 1993-10-14 1994-12-13 The Dow Chemical Company Method for conversion of halogenated hydrocarbons to halohydrins
US5523209A (en) * 1994-03-14 1996-06-04 The Scripps Research Institute Methods for identifying inhibitors of integrin activation
US5503977A (en) * 1994-04-22 1996-04-02 California Institute Of Technology Split ubiquitin protein sensor
JP3583489B2 (ja) 1994-12-22 2004-11-04 日清紡績株式会社 カルボジイミド誘導体
CH689633A5 (de) 1995-01-10 1999-07-30 Von Roll Umwelttechnik Ag Verfahren zur Kuehlung und Reinigung von Rauchgasen.
WO1997014740A1 (en) * 1995-10-19 1997-04-24 Receptagen Corporation Discrete-length polyethylene glycols
US6537776B1 (en) * 1999-06-14 2003-03-25 Diversa Corporation Synthetic ligation reassembly in directed evolution
US5786428A (en) * 1996-03-27 1998-07-28 California Institute Of Technology Adsorbents for amino acid and peptide separation
US6255461B1 (en) * 1996-04-05 2001-07-03 Klaus Mosbach Artificial antibodies to corticosteroids prepared by molecular imprinting
US6162931A (en) 1996-04-12 2000-12-19 Molecular Probes, Inc. Fluorinated xanthene derivatives
US5945526A (en) * 1996-05-03 1999-08-31 Perkin-Elmer Corporation Energy transfer dyes with enhanced fluorescence
US6416733B1 (en) * 1996-10-07 2002-07-09 Bristol-Myers Squibb Pharma Company Radiopharmaceuticals for imaging infection and inflammation
US5932421A (en) * 1996-12-06 1999-08-03 The Scripps Research Institute Methods and cell lines for identification of regulators of integrin activation
JP2001512317A (ja) * 1997-02-13 2001-08-21 ザ ダウ ケミカル カンパニー 組換えハロ脂肪族デハロゲナーゼ
US6333154B1 (en) * 1997-12-04 2001-12-25 Institut Pasteur Bacterial multi-hybrid system and applications thereof
AU3879300A (en) * 1999-03-09 2000-09-28 Diversa Corporation End selection in directed evolution
AU2594301A (en) 1999-12-23 2001-07-03 Maxygen, Inc. Alteration of hydrolase genes and screening of the resulting libraries for the ability to catalyze specific reactions
FR2804116B1 (fr) 2000-01-20 2002-08-23 Centre Nat Rech Scient Composes organosilicies, leur procede de preparation et leurs utilisations
WO2001060415A1 (en) 2000-02-18 2001-08-23 The Immune Response Corporation Methods and compositions for gene delivery
CA2403296A1 (en) 2000-04-10 2001-10-18 Benjamin F. Cravatt Proteomic analysis using activity-based probe libraries
US7879540B1 (en) 2000-08-24 2011-02-01 Promega Corporation Synthetic nucleic acid molecule compositions and methods of preparation
CA2424300A1 (en) 2000-10-02 2002-04-11 Molecular Probes, Inc. Reagents for labeling biomolecules having aldehyde or ketone moieties
CA2846761A1 (en) 2000-12-01 2002-09-06 Verenium Corporation Enzymes having dehalogenase activity and methods of use thereof
JP2005502310A (ja) 2000-12-01 2005-01-27 ディヴァーサ コーポレイション ハイドロラーゼ酵素および速度論的分割における用途
US6800453B2 (en) 2001-01-23 2004-10-05 President And Fellows Of Harvard College Nucleic-acid programmable protein arrays
DE60212642T2 (de) 2001-04-10 2007-06-14 ECOLE POLYTECHNIQUE FéDéRALE DE LAUSANNE Verfahren zur verwendung von o6-alkylguanin-dna-alkyltransferasen
AU2002359376B2 (en) 2001-11-08 2008-01-10 Elan Pharmaceuticals, Inc. N, N'-substituted-1,3-diamino-2-hydroxypropane derivatives
US20040180378A1 (en) 2002-07-19 2004-09-16 Eileen Tozer Fluorescent proteins, nucleic acids encoding them and methods for making and using them
US20040152880A1 (en) 2002-11-22 2004-08-05 Carnegie Mellon University Compositions and methods for the reversible capture of biomolecules
EP2341134B1 (en) * 2003-01-31 2014-08-27 Promega Corporation Covalent tethering of functional groups to proteins
US7429472B2 (en) * 2003-01-31 2008-09-30 Promega Corporation Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule
US20050095651A1 (en) 2003-08-12 2005-05-05 The Regents Of The University Of California Photoswitchable method for the ordered attachment of proteins to surfaces
US8293503B2 (en) 2003-10-03 2012-10-23 Promega Corporation Vectors for directional cloning
US20070087400A1 (en) 2004-07-30 2007-04-19 Aldis Darzins Covalent tethering of functional groups to proteins and substrates therefor
US7425436B2 (en) 2004-07-30 2008-09-16 Promega Corporation Covalent tethering of functional groups to proteins and substrates therefor
EP1989548A2 (en) 2006-02-08 2008-11-12 Promega Corporation Compositions and methods for capturing and analyzing cross-linked biomolecules
EP2087107A2 (en) 2006-10-30 2009-08-12 Promega Corporation Mutant hydrolase proteins with enhanced kinetics and functional expression

Similar Documents

Publication Publication Date Title
JP2013078329A5 (https=)
JP2016523959A5 (https=)
KR101319202B1 (ko) ｐＬＤＨ에 특이적으로 결합하는 ＤＮＡ 압타머
JP2009533033A5 (https=)
JP2014193932A5 (https=)
JP2016521250A5 (https=)
JP2012115275A5 (https=)
JP2016525100A5 (https=)
EA201001881A1 (ru) Пролинспецифичная протеаза из penicillium chrysogenum
EP2497777A3 (en) Mutant double cyclized receptor peptides inhibiting beta 1-adrenoceptor antibodies
RU2015103777A (ru) Кооперативные праймеры, зонды и их применения
CN101928767A (zh) 用于检测慢性粒细胞白血病bcr/abl融合基因的电化学dna生物传感器
JP2014533115A5 (https=)
SG195302A1 (en) Shk-based pharmaceutical compositions and methods of manufacturing and using the same
US20210254047A1 (en) Proximity interaction analysis
JP2017521654A5 (https=)
JP2017060521A5 (https=)
JP2012506237A5 (https=)
DK2004814T3 (da) Gruppe af nye enantioselektive mikrobielle nitrilhydrataser med bred substratspecificitet
WO2009090269A3 (en) Markers and diagnostic methods for metastasis
EP2554672A4 (en) NUCLEIC ACID STRUCTURE, METHOD FOR PRODUCING A COMPLEX AND SCREENING METHOD THEREFOR
JP2017160272A5 (https=)
US10577396B2 (en) Tolan compound
JP2013055917A5 (https=)
JP2016158578A5 (https=)